Amgen Issues Warning on Drug
- Share via
Amgen Inc. sent a letter to doctors warning that high doses of anemia drugs, including the company’s Aranesp, might be dangerous for cancer patients.
Anemia medicines are used to boost levels of red blood cells in cancer patients.
Amgen said it issued the letter after studies of similar drugs sold by Roche Holding and Johnson & Johnson showed a higher death rate in patients whose red-blood cell levels exceeded targets.
“We agree with regulatory authorities that the observation warranted communication to prescribers,” Amgen spokeswoman Trish Hawkins said.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
